ESC Professional Premium Access

Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation

Congress Presentation

About the speaker

Doctor Elisa Hennings

University Hospital Basel, Basel (Switzerland)
0 follower

5 more presentations in this session

Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.

Speaker: Professor L. Fauchier (Tours, FR)


Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND

Speaker: Mr A. Al Mubarak (Groningen, NL)


Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry

Speaker: Doctor G. Romiti (Rome, IT)


Prediction of incident atrial fibrillation with GDF-15 and echocardiographic left atrial volumes: data from the Akershus cardiac examination 1950 study

Speaker: Doctor P. Roenningen (Baerum, NO)


Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Speaker: Doctor W. Ding (Liverpool, GB)


Access the full session

Epidemiological aspects of atrial fibrillation

Speakers: Doctor E. Hennings, Professor L. Fauchier, Mr A. Al Mubarak, Doctor G. Romiti, Doctor P. Roenningen...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb